Conformis announced that the first procedure with the company’s new Actera Hip System has been performed. The new system is currently rolling out to select sites across the U.S., and the company anticipates the full commercial launch of Actera in mid-2023. Actera will feature several personalization options for surgeons to choose what best fits their patients, even for complex anatomies.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on CFMS:
